Navigation Links
Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported
Date:7/2/2009

per 100,000 women aged 0 to 84). There was an increase among all groups studied: +9.4 percent in people aged 45 to 64; +11.7 percent in people aged 64 to 75 and +15.7% over 75 years old.

But the most important finding of the study reveals that the highest increase in the incidence rate per 100,000 was observed among women below 45: +28.6 percent in people 25 to 44.

The new analysis examines the number of major surgeries (mastectomies and quadrantectomies) attributed to breast cancer over six years and by age group. Their results show that over that period, 100,745 mastectomies and 168,147 quadrantectomies were performed. A total of 41,608 major surgeries due to breast cancer were performed in the year 2000, a figure that rose to 47,200 in 2005, signifying a 13.8 percent rise over the six years.

By comparison, official estimations from the Italian Ministry of Health tallied only 37,300 cases in the year 2005.

Until now, official epidemiological data concerning the incidence of breast cancer in Italy has been computed using a statistical model (MIAMOD--Morality-Incidence Analysis MODel) based on mortality and survival data. The newly published analysis relies on hospitalization databases that track major breast surgeries.

The current study notes that while use of MIAMOD may be justified in light of the need to evaluate the incidence of all tumors, the figures may underestimate the number of breast cancers, since many deaths that occur at home or in hospital settings might be attributed to cardiovascular causes on the statistical form filled out by physicians.

Sbarro Health Research Organization (www.shro.org), a nonprofit charitable organization, is a leader in cancer, cardiovascular, and diabetes research, and supports the Sbarro Institute for Cancer Research and Molecular Medicine located at the Center for Biot
'/>"/>

SOURCE Sbarro Health Research Organization
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study shows PET can measure effectiveness of novel breast cancer treatment
2. Working Moms Find Freedom to Use Breast Pumps Where They Want, When They Want
3. The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania
4. Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
5. Metabolic factors may play a role in risk for breast cancer
6. Metabolic Syndrome May Make Breast Cancer More Likely
7. Save the ta-tas Calling on Women to Join the Love/Avon Army of Women to Unlock the Key to Breast Cancer Prevention
8. Breast Cancer Numbers Dip Most in Wealthy, Urban Areas
9. The Breast Center at Houston Northwest Medical Center Receives Prestigious National Award
10. What should a teenage girl do if she finds a lump in her breast?
11. Researchers develop new and efficient breast biopsy technique

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... CRME TSX: COM , VANCOUVER, Nov. 6 /PRNewswire-... / TSX: COM) today announced that it will report f...mber 30, 2009 on the morning of Monday, November 9...nd webcast at 9:00am Eastern (6:00am Pacific) on t...onference call, please dial 416-695-7806 or 888-78...
(Date:11/6/2009)...AINS, N.Y., Nov. 6 The Leukemia & Lymphom... Inc.,s Give & Get program, which in its first...ed more than $1 million to support LLS,s blood can...port services. ,, During the campaign, taking plac... downloadable 30% discount coupons participants...
(Date:11/6/2009)...ON, Nov. 6 The U.S. bishops sent an urgent messag... as House members steeped themselves in debate ove...re reform bill. ,, Moments before meeting to discu...lled for "a fair process" that would permit discus...eral law on abortion funding and conscience protec...
(Date:11/6/2009)...ton, VA)--Three leading scientific organizations s...ed a letter to President Obama today expressing th...nce concerning the use of personal protective equi...ected or confirmed cases of 2009 H1N1 influenza. ...a (SHEA), the Infectious Diseases Society of Ameri...
(Date:11/6/2009)... limitations seem to wane as years go by, research...) -- New research suggests that people with multip...f developing the disease are more likely to suffer...hers with the condition. , The findings, published...disease who relapse within five years of developin...
Breaking Medicine News(10 mins):Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2
...ters has received the first annual Vision Award fo...ted process to dramatically increase the processin...a. , Irvine, CA (Vocus) O... improvement programs by doing just that. LifeMa...
...Prof. Weihong Song, who is also the Jack Brown and... at UBC, found that if Valproic Acid (VPA) is used...it is reversed. , The study, published in the Jou...In doing so, plaque formation is discontinued. Amy...
...ates Multiple Password Problem With,Single Sign-On...linical and Business Appli...System, one of,the largest healthcare systems in A...up and running with single sign-on (SSO),and conte...
...T -- UCB announced,today the company has joined th...ucation Foundation (REF) as a Pinnacle sponsor of ... Rheumatoid Arthritis." The,announcement was made ... disease can be eradicated and this will happen on...
...ious atrial fibrillation, review finds, , ...bone-building medications known as bisphosphonates.... , A review of available research concludes that ... strokes. , "In addition to possible gastrointesti...
...Corporation,(Nasdaq: HLTH ) announced today that ...o 80,000,000 shares of its common stock at a price... to be purchased in the tender offer,represents ap...t on October 24, 2008 was $8.06 per share., The t...
Other Medicine News:Health News:LifeMasters Receives 2008 Vision Award for Business Impact 2Health News:LifeMasters Receives 2008 Vision Award for Business Impact 3Health News:Baptist Health System Deploys Sentillion's Vergence Solution to Provide Secure Identity and Access Management to 3,000 Clinicians 2Health News:Baptist Health System Deploys Sentillion's Vergence Solution to Provide Secure Identity and Access Management to 3,000 Clinicians 3Health News:UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign 2Health News:UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign 3Health News:Osteoporosis Meds Linked to Heart Problem 2Health News:Osteoporosis Meds Linked to Heart Problem 3Health News:HLTH Corporation Announces Commencement of Its Tender Offer 2Health News:HLTH Corporation Announces Commencement of Its Tender Offer 3Health News:HLTH Corporation Announces Commencement of Its Tender Offer 4
(Date:11/6/2009)...Newswire-FirstCall/ -- Oxygen Biotherapeutics, Inc...a previously approved reverse split of its common ...Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted ...ade under the new symbol OXBT. The stock also will...lit becomes effective. ,, "This reverse split w...
(Date:11/6/2009)...swire/ -- Trius Therapeutics, Inc. announced today...m S-1 with the U.S. Securities and Exchange Commis...ffering of shares of its common stock. All shares ...l be offered by the Company. ,, Credit Suisse S... manager, Piper Jaffray & Co. is acting as co-...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Roper Industries, Inc. ... definitive agreement to acquire Verathon, Inc., a... The Verathon Board of Directors has approved the ...y regulatory approvals and closing conditions, inc...he closing to be completed in early December. ,...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 1ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 2ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 3GREENBioPharma Dec 2 3 2009 10591 1Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2
...d Condition, WASHINGTON, May 22, 2007 /PRNewswire-...dies today regarding pediatric patients,with gastr...poster,sessions at the annual Digestive Disease We...r. , The studies being presented further support A... gastrointestinal health among,the pediatric popul...
...osei Group,Corporation , a biopharmaceutical compa... study of its fentanyl sublingual spray,(AD 923), ...eakthrough pain. , This was a pharmacokinetic Phas...over, randomised study of AD 923 versus Actiq(R),(...rsus fentanyl,citrate injection. The study was con...
Other Medicine Technology:New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 2New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 3New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 4New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 5Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3
LB Agarose Plates
LB Top Agarose 100ml Bottle
LB Agar (Bottle)
LB Broth with 7.5% Glycerol
Medicine Products: